No matches
Pulmonology

CRSwNP at Center Stage: Impact of Biologics in Patients with Co-existing Type 2 Asthma

In this video soundbite from the EAACI 2025 symposium, Dr. Philippe Gevaert explains how biologic options for uncontrolled CRSwNP are increasing, and phase 3 studies of approved biologics show improved outcomes and decreased SCS use/surgery in patients with CRSwNP. Additionally, he explains how biologics targeting type 2 inflammatory pathophysiology potentially improve outcomes for eligible patients with co-existing CRSwNP and asthma.
Philippe Gevaert
MD, PhD
Philippe Gevaert

Related resources

Spotlight on Type 2 Inflammation in the Upper and Lower Airways

Spotlight on Type 2 Inflammation in the Upper and Lower Airways

expert video
Compounded Burden of Co-existing Type 2 Airway Diseases

Compounded Burden of Co-existing Type 2 Airway Diseases

expert video
Connecting Type 2 Inflammation to CRSwNP

Connecting Type 2 Inflammation to CRSwNP

expert video
Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management

Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management

interactivity
How often do you suggest to assess sense of smell?

How often do you suggest to assess sense of smell?

expert video
What Do We Know About Type 2 Inflammation in COPD?

What Do We Know About Type 2 Inflammation in COPD?

expert video
ERS 2024 | How Can Biologics Help Achieve Clinical Remission in Children With Severe Asthma?

ERS 2024 | How Can Biologics Help Achieve Clinical Remission in Children With Severe Asthma?

expert video
Role of Type 2 Cytokines in Asthma and COPD

Role of Type 2 Cytokines in Asthma and COPD

expert video
GINA-Based Opportunities for Improved Outcomes With Effective Management of Pediatric Asthma in Children 6-11 Years of Age

GINA-Based Opportunities for Improved Outcomes With Effective Management of Pediatric Asthma in Children 6-11 Years of Age

interactivity
Type 2 Inflammation Is a Significant Driver of Pediatric Severe Asthma

Type 2 Inflammation Is a Significant Driver of Pediatric Severe Asthma

Infographic
What proportion of patients can achieve control in CRSwNP?

What proportion of patients can achieve control in CRSwNP?

expert video
The Heterogeneity of Underlying Inflammation in Patients With COPD

The Heterogeneity of Underlying Inflammation in Patients With COPD

expert video
ERS 2024 | Understanding Remission as a Treatment Goal in Pediatric Severe Asthma – Patient Case Follow-Up

ERS 2024 | Understanding Remission as a Treatment Goal in Pediatric Severe Asthma – Patient Case Follow-Up

expert video
Exacerbations Lead to Worsening Lung Function

Exacerbations Lead to Worsening Lung Function

expert video
CRSwNP Significantly Affects the Quality of Life of CRSwNP Patients

CRSwNP Significantly Affects the Quality of Life of CRSwNP Patients

interactivity
How Can Poor Lung Function Impact Asthma Burden in Adult Patients?

How Can Poor Lung Function Impact Asthma Burden in Adult Patients?

videoanimation
EAACI 2024 On-Treatment Clinical Remission in Upper and Lower Airways: Going Beyond Symptom Control

EAACI 2024 On-Treatment Clinical Remission in Upper and Lower Airways: Going Beyond Symptom Control

expert video
What Are the Key Inflammatory Processes in Patients with COPD?

What Are the Key Inflammatory Processes in Patients with COPD?

expert video
ERS 2024 | Understanding the Complex Pathophysiology of COPD

ERS 2024 | Understanding the Complex Pathophysiology of COPD

expert video
CRSwNP Interactive Patient Case Tool

CRSwNP Interactive Patient Case Tool

interactivity
FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients

FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients

Infographic
ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe Asthma?

ADVENT On Air | What Is the Future Outlook for Remission in Pediatric Severe Asthma?

Podcast
How Can Poor Lung Function Impact Asthma Burden in Pediatric Patients?

How Can Poor Lung Function Impact Asthma Burden in Pediatric Patients?

videoanimation
Pathways to Disease: Inflammation in Chronic Obstructive Pulmonary Disease Video

Pathways to Disease: Inflammation in Chronic Obstructive Pulmonary Disease Video

videoanimation
ERS 2023 | The Evolving Clinical Landscape in COPD and Implications for Disease Management

ERS 2023 | The Evolving Clinical Landscape in COPD and Implications for Disease Management

expert video
ERS 2024 | What Do We Know About IL-33 Genetics?

ERS 2024 | What Do We Know About IL-33 Genetics?

expert video
Uncovering the Impact of Moderate COPD Exacerbations

Uncovering the Impact of Moderate COPD Exacerbations

interactivity
Head-to-Head Trials of Biologics in CRSwNP

Head-to-Head Trials of Biologics in CRSwNP

expert video
ADVENT On Air | Loss of Smell in CRSwNP Patients

ADVENT On Air | Loss of Smell in CRSwNP Patients

Podcast
Type 2 Inflammation and Airway Remodeling Drive Lung Function Decline

Type 2 Inflammation and Airway Remodeling Drive Lung Function Decline

videoanimation
Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity

Chronic Obstructive Pulmonary Disease: Disease Burden & Heterogeneity

interactivity
Blood Eosinophils: A Biomarker in COPD

Blood Eosinophils: A Biomarker in COPD

Infographic
ERS 2024 | Pediatric Severe Asthma: Is Clinical Remission Possible?

ERS 2024 | Pediatric Severe Asthma: Is Clinical Remission Possible?

expert video
Eosinophils: A Biomarker in COPD

Eosinophils: A Biomarker in COPD

Infographic
Indirect Treatment Comparison of Biologics Approved for CRSwNP

Indirect Treatment Comparison of Biologics Approved for CRSwNP

expert video
GOLD Diagnosis and Assessment of COPD

GOLD Diagnosis and Assessment of COPD

expert video
Lung Function Assessment Is a Fundamental Component of Optimal Asthma Care

Lung Function Assessment Is a Fundamental Component of Optimal Asthma Care

videoanimation
ADVENT On Air | Pulmonary Perspectives: Understanding COPD Patient Burden

ADVENT On Air | Pulmonary Perspectives: Understanding COPD Patient Burden

Podcast
ADVENT On Air | Breathing Easy: Navigating Lung Function in Pediatric Severe Asthma With Spirometry and Beyond

ADVENT On Air | Breathing Easy: Navigating Lung Function in Pediatric Severe Asthma With Spirometry and Beyond

Podcast
ADVENT On Air | Diving Deep: Exploring the Impact of Airway Remodeling in Severe Asthma

ADVENT On Air | Diving Deep: Exploring the Impact of Airway Remodeling in Severe Asthma

Podcast
Lung Function Decline: Why it Matters and What’s at Stake for Patients

Lung Function Decline: Why it Matters and What’s at Stake for Patients

interactivity
Type 2 Inflammation: Links With Severe Uncontrolled CRSwNP

Type 2 Inflammation: Links With Severe Uncontrolled CRSwNP

expert video
ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Podcast
On-Treatment Clinical Remission in Asthma Patients Case Tool

On-Treatment Clinical Remission in Asthma Patients Case Tool

interactivity
GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

GOLD 2023 | Beyond a One Size Fits All Approach: Recognizing the Heterogeneity of COPD

expert video
Mucus Plugging Is a Key Component of Remodeling in Asthma, Leading to Fixed Airway Obstruction

Mucus Plugging Is a Key Component of Remodeling in Asthma, Leading to Fixed Airway Obstruction

Infographic
How Can FeNO Measurement Improve Severe Asthma Management?

How Can FeNO Measurement Improve Severe Asthma Management?

expert video
ERS-ISIAN 2025 | Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions

ERS-ISIAN 2025 | Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions

expert video
Worsening Disease Results in a Vicious Cycle of COPD (2025 Update)

Worsening Disease Results in a Vicious Cycle of COPD (2025 Update)

interactivity
ADVENT On Air | Remission in CRSwNP

ADVENT On Air | Remission in CRSwNP

Podcast

Learning objectives

  • To discuss the impact of co-existing type 2 inflammatory diseases on patient burden and management approaches
Tags
quality of lifebiologicsexpert insightssymposiumtype 2 inflammationasthmaCRSwNP
MAT-GLB-2505227 - 1.0 - 09/2025

About this expert

Allergy/Immunology
Rhinology

Philippe Gevaert

MD, PhD

Professor of Rhinology and Allergy in the Department of Otorhinolaryngology | Ghent University, Belgium

See author’s profile
Philippe Gevaert

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: AlgeriaChange country/region